文献速递消化系统肿瘤

结直肠癌免疫逃逸的遗传机制

Genetic Mechanisms of Immune Evasion in Colorectal Cancer.
PubMed 文献 · Cancer Discov · 2018-03-06

该研究分析了1211例结直肠癌原发肿瘤样本(含179例微卫星高度不稳定型),发现MSI-high亚型在免疫调节通路和抗原呈递机制中存在显著突变,包括B2M和HLA基因的双等位缺失;WNT/β-catenin信号基因在所有亚型中显著突变,其激活与T细胞浸润缺失相关。

要点

  • MSI-high结直肠癌虽高突变负荷且淋巴细胞浸润频繁,但常发生免疫编辑以逃避免疫。
  • B2M和HLA基因双等位缺失(拷贝数改变或拷贝中性LOH)是MSI-high免疫逃逸机制之一。
  • WNT/β-catenin信号激活与T细胞排斥相关,WNT抑制剂或可逆转免疫排斥。

核心结论

  • MSI-high结直肠癌常经历免疫编辑,获得遗传事件以逃避免疫攻击。
  • 结直肠癌肿瘤具有与WNT信号激活和T细胞排斥相关的遗传和甲基化事件。

研究设计与样本

  • 分析1211例结直肠癌原发肿瘤样本,包括179例MSI-high。
  • 包含TCGA结直肠癌队列592例样本。

主要发现

  • MSI-high在免疫调节通路和抗原呈递机制中显著突变率高。
  • B2M和HLA基因因拷贝数改变和拷贝中性LOH发生双等位缺失。
  • WNT/β-catenin信号基因在所有结直肠癌亚型中显著突变。
  • 激活的WNT/β-catenin信号与T细胞浸润缺失相关。

临床怎么用

  • 可更好地监测对免疫阻断治疗应答的15%病例的耐药性。
  • 可使用WNT信号抑制剂逆转目前不响应的85%病例的免疫排斥。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To understand the genetic drivers of immune recognition and evasion in colorectal cancer, we analyzed 1,211 colorectal cancer primary tumor samples, including 179 classified as microsatellite instability-high (MSI-high). This set includes The Cancer Genome Atlas colorectal cancer cohort of 592 samples, completed and analyzed here. MSI-high, a hypermutated, immunogenic subtype of colorectal cancer, had a high rate of significantly mutated genes in important immune-modulating pathways and in the antigen presentation machinery, including biallelic losses of B2M and HLA genes due to copy-number alterations and copy-neutral loss of heterozygosity. WNT/β-catenin signaling genes were significantly mutated in all colorectal cancer subtypes, and activated WNT/β-catenin signaling was correlated with the absence of T-cell infiltration. This large-scale genomic analysis of colorectal cancer demonstrates that MSI-high cases frequently undergo an immunoediting process that provides them with genetic events allowing immune escape despite high mutational load and frequent lymphocytic infiltration and, furthermore, that colorectal cancer tumors have genetic and methylation events associated with activated WNT signaling and T-cell exclusion.Significance: This multi-omic analysis of 1,211 colorectal cancer primary tumors reveals that it should be possible to better monitor resistance in the 15% of cases that respond to immune blockade therapy and also to use WNT signaling inhibitors to reverse immune exclusion in the 85% of cases that currently do not. Cancer Discov; 8(6); 730-49. ©2018 AACR.This article is highlighted in the In This Issue feature, p. 663.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Grasso CS, Giannakis M, Wells DK, et al. Genetic Mechanisms of Immune Evasion in Colorectal Cancer. Cancer Discov. 2018. PMID: 29510987. doi:10.1158/2159-8290.CD-17-1327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。